TRP_1170x120_3-8-19

Dr. Scott Gottlieb

FDA issues statement on new policy for pricing of generic drugs

FDA issues statement on new policy for pricing of generic drugs

SILVER SPRING, Md. — FDA Commissioner Dr. Scott Gottlieb issued the following statement Friday on a new policy to improve access and foster price competition for drugs that face inadequate generic competition: “In too many cases, branded drugs that are no longer protected by patents or other exclusivities do not face expected competition. In fact,

Government shutdown having major effect on FDA

Government shutdown having major effect on FDA

WASHINGTON — The U.S. Food and Drug Administration has roughly five weeks of funding left to review new drug applications during the shutdown, commissioner Dr. Scott Gottlieb reported this past week on Twitter. Many experts predict this could have a ripple effect, bogging down the approval and manufacture of new drugs, delaying patients from getting these treatments and

CVS praises FDA’s steps to curtail sales of e-cigarettes to nation’s youth

CVS praises FDA’s steps to curtail sales of e-cigarettes to nation’s youth

WOONSOCKET, R.I. — As the nation’s first and only national pharmacy chain to have eliminated the sale of cigarettes and other harmful tobacco products from its retail stores and having never sold e-cigarettes and vaping devices CVS Health today applauded the enforcement actions taken by the U.S. Food and Drug Administration (FDA) to curtail the